Skip to main content
INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.310
-0.020 (-1.50%)
At close: Mar 9, 2026, 4:00 PM EDT
1.299
-0.011 (-0.82%)
After-hours: Mar 9, 2026, 7:00 PM EDT

INmune Bio Revenue

INmune Bio had revenue of $50.00K in the twelve months ending September 30, 2025, up 19.05% year-over-year. In the year 2024, INmune Bio had annual revenue of $14.00K, down -90.97%.

Revenue (ttm)
$50.00K
Revenue Growth
+19.05%
P/S Ratio
723.12
Revenue / Employee
$2,273
Employees
22
Market Cap
34.83M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202414.00K-141.00K-90.97%
Dec 31, 2023155.00K-219.00K-58.56%
Dec 31, 2022374.00K193.00K106.63%
Dec 31, 2021181.00K170.00K1,545.45%
Dec 31, 202011.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Atara Biotherapeutics 151.93M
Celularity 40.58M
NovaBay Pharmaceuticals 10.30M
Pluri 1.34M
Lisata Therapeutics 1.07M
ABVC BioPharma 797.92K
Outlook Therapeutics 205.70K
Actinium Pharmaceuticals 90.00K
Revenue Rankings

INMB News

More News